Search research articles
Contact Us
Filters
Showing results (471-480 of 481) with videos related to
Page
of 49
Sort By:
ACS Synthetic Biology
|
October 11, 2016
Paired Design of dCas9 as a Systematic Platform for the Detection of Featured Nucleic Acid Sequences in Pathogenic Strains
Yihao Zhang, Long Qian, Weijia Wei, et al.
Free Radical Biology & Medicine
|
September 18, 2024
Lanthanum chloride exerts therapeutic potential for chronic kidney disease by suppressing nanohydroxyapatite-induced mitophagy and mitochondria-mediated apoptosis
Li Zhu, Lu-Yu Wang, Ting Zhang, et al.
Radiology
|
March 28, 2018
Alterations of White Matter Connectivity in Preschool Children with Autism Spectrum Disorder
Shi-Jun Li, Yi Wang, Long Qian, et al.
Journal of Cellular and Molecular Medicine
|
May 25, 2019
Copy number variations and polymorphisms in HSP90AB1 and risk of systemic lupus erythematosus and efficacy of glucocorticoids
Man Zhang, Yuanyuan Gu, Shunwei Huang, et al.
Genes & Genomics
|
June 17, 2018
Associations of HSP90AA2 gene polymorphisms with disease susceptibility, glucocorticoids efficacy and health-related quality of life in Chinese systemic lupus erythematosus patients
Man Zhang, Su-Su Li, Qiao-Mei Xie, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
May 27, 2020
Hsp70 Gene Polymorphisms Are Associated With Disease Susceptibility and HRQOL Improvement in Chinese Han Population With Systemic Lupus Erythematosus
Qiao-Mei Xie, Qiu-Yue Lou, Shun-Wei Huang, et al.
Annals of the Rheumatic Diseases
|
February 7, 2025
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Jinjing Liu, Ying Jiang, Shangzhu Zhang, et al.
Annals of the Rheumatic Diseases
|
November 27, 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Jinjing Liu, Ying Jiang, Shangzhu Zhang, et al.
American Journal of Clinical and Experimental Immunology
|
May 15, 2018
Association of HSP90B1 genetic polymorphisms with efficacy of glucocorticoids and improvement of HRQoL in systemic lupus erythematosus patients from Anhui Province
Xiu-Xiu Sun, Su-Su Li, Man Zhang, et al.
Plos One
|
December 28, 2020
High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy
Jacob S Stevens, Kristen L King, Shelief Y Robbins-Juarez, et al.
Page
of 49
Search research articles
Search
Showing results (471-480 of 481) with videos related to
Sort By:
Page
of 49
ACS Synthetic Biology
|
October 11, 2016
Paired Design of dCas9 as a Systematic Platform for the Detection of Featured Nucleic Acid Sequences in Pathogenic Strains
Yihao Zhang, Long Qian, Weijia Wei, et al.
Free Radical Biology & Medicine
|
September 18, 2024
Lanthanum chloride exerts therapeutic potential for chronic kidney disease by suppressing nanohydroxyapatite-induced mitophagy and mitochondria-mediated apoptosis
Li Zhu, Lu-Yu Wang, Ting Zhang, et al.
Radiology
|
March 28, 2018
Alterations of White Matter Connectivity in Preschool Children with Autism Spectrum Disorder
Shi-Jun Li, Yi Wang, Long Qian, et al.
Journal of Cellular and Molecular Medicine
|
May 25, 2019
Copy number variations and polymorphisms in HSP90AB1 and risk of systemic lupus erythematosus and efficacy of glucocorticoids
Man Zhang, Yuanyuan Gu, Shunwei Huang, et al.
Genes & Genomics
|
June 17, 2018
Associations of HSP90AA2 gene polymorphisms with disease susceptibility, glucocorticoids efficacy and health-related quality of life in Chinese systemic lupus erythematosus patients
Man Zhang, Su-Su Li, Qiao-Mei Xie, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
May 27, 2020
Hsp70 Gene Polymorphisms Are Associated With Disease Susceptibility and HRQOL Improvement in Chinese Han Population With Systemic Lupus Erythematosus
Qiao-Mei Xie, Qiu-Yue Lou, Shun-Wei Huang, et al.
Annals of the Rheumatic Diseases
|
February 7, 2025
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Jinjing Liu, Ying Jiang, Shangzhu Zhang, et al.
Annals of the Rheumatic Diseases
|
November 27, 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Jinjing Liu, Ying Jiang, Shangzhu Zhang, et al.
American Journal of Clinical and Experimental Immunology
|
May 15, 2018
Association of HSP90B1 genetic polymorphisms with efficacy of glucocorticoids and improvement of HRQoL in systemic lupus erythematosus patients from Anhui Province
Xiu-Xiu Sun, Su-Su Li, Man Zhang, et al.
Plos One
|
December 28, 2020
High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy
Jacob S Stevens, Kristen L King, Shelief Y Robbins-Juarez, et al.
Page
of 49